Brief: J&J Receives U.S. FDA 510(K) Clearance For Monarch Quest 3
17/08/2026 13:33
BRIEF-J&J Receives U.S. FDA 510(K) Clearance For Monarch Quest 3 Aug 17 (Reuters) - Johnson & Johnson JNJ.N:
JOHNSON & JOHNSON ANNOUNCES MONARCH™ QUEST 3, ADVANCING THE LATEST IN ROBOTICALLY-ASSISTED BRONCHOSCOPY
Further company coverage: JNJ.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Johnson & Johnson
See all newsEli Lilly hits record high as healthcare stocks rally
Kenvue loses bid for rehearing after Tylenol autism lawsuits revived (updated)
Brief: Johnson & Johnson Announces New Data For Tremfya
Kenvue loses bid for rehearing after Tylenol autism lawsuits revived
Health Rounds: Glucose monitoring devices for type 2 diabetes benefit even those not on insulin